Streamline Health Solutions Inc (STRM)

$2.46

+0.1

(+4.24%)▲

Market is closed - opens 7 PM, 15 Oct 2024

Performance

  • $2.32
    $2.55
    $2.46
    downward going graph

    5.69%

    Downside

    Day's Volatility :9.15%

    Upside

    3.67%

    downward going graph
  • $2.03
    $11.99
    $2.46
    downward going graph

    17.48%

    Downside

    52 Weeks Volatility :83.07%

    Upside

    79.49%

    downward going graph

Returns

PeriodStreamline Health Solutions IncIndex (Russel 2000)
3 Months
-68.84%
0.0%
6 Months
-53.73%
0.0%
1 Year
-34.47%
0.0%
3 Years
-90.91%
-22.2%

Highlights

Market Capitalization
10.0M
Book Value
$0.75
Earnings Per Share (EPS)
-4.88
PEG Ratio
-0.44
Wall Street Target Price
1.5
Profit Margin
-92.72%
Operating Margin TTM
-71.44%
Return On Assets TTM
-10.54%
Return On Equity TTM
-80.09%
Revenue TTM
20.3M
Revenue Per Share TTM
5.25
Quarterly Revenue Growth YOY
-0.7000000000000001%
Gross Profit TTM
11.5M
EBITDA
-6.4M
Diluted Eps TTM
-4.88
Quarterly Earnings Growth YOY
12.13
EPS Estimate Current Year
-0.34
EPS Estimate Next Year
-0.11
EPS Estimate Current Quarter
-0.04
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Streamline Health Solutions Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 39.02%

Current $2.46
Target $1.50

Company Financials

FY19Y/Y Change
Revenue
22.4M
↓ 8.11%
Net Income
-5.9M
↑ 89.24%
Net Profit Margin
-26.22%
↓ 13.49%
FY20Y/Y Change
Revenue
20.7M
↓ 7.25%
Net Income
-2.9M
↓ 51.18%
Net Profit Margin
-13.8%
↑ 12.42%
FY21Y/Y Change
Revenue
11.3M
↓ 45.3%
Net Income
-4.8M
↑ 67.62%
Net Profit Margin
-42.3%
↓ 28.5%
FY22Y/Y Change
Revenue
17.4M
↑ 53.17%
Net Income
-6.9M
↑ 44.13%
Net Profit Margin
-39.8%
↑ 2.5%
FY23Y/Y Change
Revenue
24.9M
↑ 43.21%
Net Income
-11.4M
↑ 64.51%
Net Profit Margin
-45.72%
↓ 5.92%
FY24Y/Y Change
Revenue
22.6M
↓ 9.21%
Net Income
-18.7M
↑ 64.31%
Net Profit Margin
-82.74%
↓ 37.02%
Q2 FY23Q/Q Change
Revenue
5.3M
↓ 20.95%
Net Income
-2.9M
↑ 32.95%
Net Profit Margin
-54.41%
↓ 22.06%
Q3 FY23Q/Q Change
Revenue
5.8M
↑ 8.21%
Net Income
-2.5M
↓ 13.31%
Net Profit Margin
-43.59%
↑ 10.82%
Q4 FY23Q/Q Change
Revenue
6.1M
↑ 6.29%
Net Income
-11.9M
↑ 373.6%
Net Profit Margin
-194.21%
↓ 150.62%
Q1 FY24Q/Q Change
Revenue
5.4M
↓ 12.59%
Net Income
-1.4M
↓ 88.5%
Net Profit Margin
-25.55%
↑ 168.66%
Q2 FY24Q/Q Change
Revenue
4.3M
↓ 19.23%
Net Income
-2.7M
↑ 99.93%
Net Profit Margin
-63.26%
↓ 37.71%
Q3 FY24Q/Q Change
Revenue
4.5M
↑ 3.37%
Net Income
-2.8M
↑ 2.34%
Net Profit Margin
-62.62%
↑ 0.64%
FY19Y/Y Change
Total Assets
31.7M
↓ 14.52%
Total Liabilities
23.1M
↑ 25.09%
FY20Y/Y Change
Total Assets
31.7M
↓ 0.28%
Total Liabilities
15.6M
↓ 32.13%
FY21Y/Y Change
Total Assets
26.0M
↓ 17.93%
Total Liabilities
8.5M
↓ 45.75%
FY22Y/Y Change
Total Assets
61.8M
↑ 137.96%
Total Liabilities
27.8M
↑ 227.18%
FY23Y/Y Change
Total Assets
61.5M
↓ 0.48%
Total Liabilities
26.0M
↓ 6.34%
FY24Y/Y Change
Total Assets
41.7M
↓ 32.15%
Total Liabilities
22.9M
↓ 11.86%
Q2 FY23Q/Q Change
Total Assets
56.5M
↓ 8.18%
Total Liabilities
23.4M
↓ 9.94%
Q3 FY23Q/Q Change
Total Assets
53.3M
↓ 5.61%
Total Liabilities
22.2M
↓ 5.18%
Q4 FY23Q/Q Change
Total Assets
41.1M
↓ 22.9%
Total Liabilities
21.4M
↓ 3.86%
Q1 FY24Q/Q Change
Total Assets
41.7M
↑ 1.54%
Total Liabilities
22.9M
↑ 7.36%
Q2 FY24Q/Q Change
Total Assets
41.7M
↓ 0.04%
Total Liabilities
24.4M
↑ 6.53%
Q3 FY24Q/Q Change
Total Assets
39.0M
↓ 6.47%
Total Liabilities
23.1M
↓ 5.3%
FY19Y/Y Change
Operating Cash Flow
1.4M
↓ 31.22%
Investing Cash Flow
-3.0M
↑ 61.01%
Financing Cash Flow
-638.0K
↓ 46.85%
FY20Y/Y Change
Operating Cash Flow
-8.0K
↓ 100.57%
Investing Cash Flow
-3.4M
↑ 13.55%
Financing Cash Flow
2.7M
↓ 521.79%
FY21Y/Y Change
Operating Cash Flow
-5.8M
↑ 71862.5%
Investing Cash Flow
9.5M
↓ 377.42%
Financing Cash Flow
-2.9M
↓ 209.36%
FY22Y/Y Change
Operating Cash Flow
-3.5M
↓ 39.13%
Investing Cash Flow
-13.2M
↓ 239.21%
Financing Cash Flow
24.1M
↓ 920.56%
FY23Y/Y Change
Operating Cash Flow
-7.1M
↑ 103.85%
Investing Cash Flow
-1.9M
↓ 85.31%
Financing Cash Flow
5.8M
↓ 76.02%
Q2 FY23Q/Q Change
Operating Cash Flow
126.0K
↓ 105.2%
Investing Cash Flow
-433.0K
↓ 11.63%
Financing Cash Flow
-304.0K
↓ 86.11%
Q3 FY23Q/Q Change
Operating Cash Flow
-1.1M
↓ 942.86%
Investing Cash Flow
-640.0K
↑ 47.81%
Financing Cash Flow
-198.0K
↓ 34.87%

Technicals Summary

Sell

Neutral

Buy

Streamline Health Solutions Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Streamline Health Solutions Inc
Streamline Health Solutions Inc
-18.9%
-53.73%
-34.47%
-90.91%
-85.5%
Solventum Corp
Solventum Corp
-5.08%
10.46%
-1.39%
-1.39%
-1.39%
Doximity, Inc.
Doximity, Inc.
9.81%
70.38%
94.74%
-42.73%
-18.28%
Veeva Systems Inc.
Veeva Systems Inc.
-2.63%
4.81%
-0.3%
-31.45%
37.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
5.07%
5.69%
36.11%
50.49%
50.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Streamline Health Solutions Inc
Streamline Health Solutions Inc
NA
NA
-0.44
-0.34
-0.8
-0.11
NA
0.75
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
54.14
54.14
2.42
0.9
0.17
0.11
NA
4.92
Veeva Systems Inc.
Veeva Systems Inc.
56.5
56.5
1.21
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
26.08
26.08
2.37
4.25
0.21
0.06
0.0
17.08
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Streamline Health Solutions Inc
Streamline Health Solutions Inc
Buy
$10.0M
-85.5%
NA
-92.72%
Solventum Corp
Solventum Corp
Hold
$10.8B
-1.39%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$8.0B
-18.28%
54.14
32.53%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.2B
37.91%
56.5
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$41.2B
50.49%
26.08
8.1%

Insights on Streamline Health Solutions Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 4.33M → 4.47M (in $), with an average increase of 3.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -1.37M → -2.80M (in $), with an average decrease of 51.1% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 100.5% return, outperforming this stock by 179.2%

  • Vs VEEV

    In the last 3 years, Streamline Health Solutions Inc has experienced a drawdown of -90.9%, however Veeva Systems Inc. resisted the overall trend and outperformed by 48.2%

Institutional Holdings

  • Harbert Fund Advisors Inc

    7.62%

  • Perkins Capital Management Inc

    3.10%

  • Vanguard Group Inc

    2.64%

  • Herald Investment Management Ltd

    1.32%

  • Nicholas Hoffman & Company, LLC

    1.17%

  • Geode Capital Management, LLC

    0.76%

Company Information

streamline health solutions, inc. supports revenue cycle optimization for healthcare enterprises. our integrated solutions, technology-enabled services and analytics enable providers to drive reimbursement in a value-based world. we share a common calling and commitment to advance the quality of life and the quality of healthcare — for society, our industry, our clients and the communities they serve, and the individual patient. all of our solutions are designed with an enterprise vision in mind. by implementing our solutions, healthcare organizations can improve the flow and management of critical patient information. each of our solutions helps transform and structure data between disparate systems into actionable information, giving you comprehensive access to clinical, financial, and administrative intelligence. our solution suites include: him, coding & cdi • clinical documentation improvement (cdi) • code auditing services & technology • enterprise content management • release of

Organization
Streamline Health Solutions Inc
Employees
77
CEO
Mr. Wyche T. Green III
Industry
Technology Services

Discover More

FAQs